212 related articles for article (PubMed ID: 27494845)
1. Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma.
Ramakrishnan V; Gomez M; Prasad V; Kimlinger T; Painuly U; Mukhopadhyay B; Haug J; Bi L; Rajkumar SV; Kumar S
Oncotarget; 2016 Aug; 7(35):56253-56265. PubMed ID: 27494845
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.
Chen KF; Lin JP; Shiau CW; Tai WT; Liu CY; Yu HC; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Aug; 84(3):268-77. PubMed ID: 22580047
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
Gallerne C; Prola A; Lemaire C
Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.
Chow KU; Nowak D; Boehrer S; Ruthardt M; Knau A; Hoelzer D; Mitrou PS; Weidmann E
Biochem Pharmacol; 2003 Sep; 66(5):711-24. PubMed ID: 12948851
[TBL] [Abstract][Full Text] [Related]
5. Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer.
Lee KM; Lee H; Han D; Moon WK; Kim K; Oh HJ; Choi J; Hwang EH; Kang SE; Im SA; Lee KH; Ryu HS
Breast Cancer Res; 2020 Nov; 22(1):130. PubMed ID: 33239070
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
Ramakrishnan V; Painuly U; Kimlinger T; Haug J; Rajkumar SV; Kumar S
Leukemia; 2014 Jul; 28(7):1519-28. PubMed ID: 24402161
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
Doudican NA; Wen SY; Mazumder A; Orlow SJ
Oncol Rep; 2012 Nov; 28(5):1851-8. PubMed ID: 22922937
[TBL] [Abstract][Full Text] [Related]
8. 15d-PGJ
Sperandio M; Demasi APD; Martinez EF; Saad SO; Pericole FV; Vieira KP; Freitas NS; Araújo VC; Brown AL; Clemente-Napimoga JT; Napimoga MH
Exp Mol Pathol; 2017 Jun; 102(3):434-445. PubMed ID: 28506771
[TBL] [Abstract][Full Text] [Related]
9. Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis.
Gomez-Bougie P; Halliez M; Moreau P; Pellat-Deceunynck C; Amiot M
Cancer Lett; 2016 Dec; 383(2):204-211. PubMed ID: 27697610
[TBL] [Abstract][Full Text] [Related]
10. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
[TBL] [Abstract][Full Text] [Related]
11. OBATOCLAX and ABT-737 induce ER stress responses in human melanoma cells that limit induction of apoptosis.
Wroblewski D; Jiang CC; Croft A; Farrelly ML; Zhang XD; Hersey P
PLoS One; 2013; 8(12):e84073. PubMed ID: 24367627
[TBL] [Abstract][Full Text] [Related]
12. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
[TBL] [Abstract][Full Text] [Related]
13. Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells.
Zhao Y; Zhang E; Lv N; Ma L; Yao S; Yan M; Zi F; Deng G; Liu X; He J; Wu W; Cai Z; Yu R
Cell Physiol Biochem; 2018; 48(2):785-800. PubMed ID: 30032136
[TBL] [Abstract][Full Text] [Related]
14. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
[TBL] [Abstract][Full Text] [Related]
15. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 protects hepatocytes against endoplasmic reticulum stress-induced apoptosis via protein kinase A-dependent induction of glucose-regulated protein 78 expression.
Yang FW; Fu Y; Li Y; He YH; Mu MY; Liu QC; Long J; Lin SD
World J Gastroenterol; 2017 Oct; 23(40):7253-7264. PubMed ID: 29142472
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells.
Tian A; Wilson GS; Lie S; Wu G; Hu Z; Hebbard L; Duan W; George J; Qiao L
Cancer Lett; 2014 Sep; 351(2):232-41. PubMed ID: 24976294
[TBL] [Abstract][Full Text] [Related]
18. IAP antagonists induce anti-tumor immunity in multiple myeloma.
Chesi M; Mirza NN; Garbitt VM; Sharik ME; Dueck AC; Asmann YW; Akhmetzyanova I; Kosiorek HE; Calcinotto A; Riggs DL; Keane N; Ahmann GJ; Morrison KM; Fonseca R; Lacy MQ; Dingli D; Kumar SK; Ailawadhi S; Dispenzieri A; Buadi F; Gertz MA; Reeder CB; Lin Y; Chanan-Khan AA; Stewart AK; Fooksman D; Bergsagel PL
Nat Med; 2016 Dec; 22(12):1411-1420. PubMed ID: 27841872
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.
Abdel Malek MA; Jagannathan S; Malek E; Sayed DM; Elgammal SA; Abd El-Azeem HG; Thabet NM; Driscoll JJ
Oncotarget; 2015 Feb; 6(5):3098-110. PubMed ID: 25605012
[TBL] [Abstract][Full Text] [Related]
20. Suppression of PI3K/Akt signaling by synthetic bichalcone analog TSWU-CD4 induces ER stress- and Bax/Bak-mediated apoptosis of cancer cells.
Lin ML; Chen SS; Huang RY; Lu YC; Liao YR; Reddy MV; Lee CC; Wu TS
Apoptosis; 2014 Nov; 19(11):1637-53. PubMed ID: 25183449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
